Behavioral phenotyping of the MPTP mouse model of Parkinson's disease (Q34420632)

2 August 2017

1 reference

title

Behavioral phenotyping of the MPTP mouse model of Parkinson's disease (English)

1 reference

2 August 2017

1 reference

Sedelis M

1

1 reference

2 August 2017

Schwarting RK

series ordinal

2

1 reference

2 August 2017

Huston JP

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Behavioural Brain Research

2 August 2017

1 reference

2 August 2017

125

1 reference

2 August 2017

109-125

1 reference

2 August 2017

1-2

1 reference

Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Atm-deficient mice: a paradigm of ataxia telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Evidence for an epileptogenic action of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The acute convulsant effect of MPTP is dependent on intracerebral MPP+.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Nest-building behavior in two cerebellar mutant mice: staggerer and weaver.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 5,7-dihydroxytryptamine on the locomotor activity and striatal amines in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of MPTP on locomotor activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPTP-induced behavioural and biochemical deficits: a parametric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effect of the competitive NMDA antagonist, CGP 40 116, and a low dose of l-Dopa on the motor activity deficit of MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of D1 and D2 agonists on spontaneous motor activity in MPTP treated mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPTP-induced hypoactivity in mice: reversal by L-dopa.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Amphetamine-induced circling behaviour in MPTP-lesioned mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Behavioural effects of angiotensin II in the mouse following MPTP administration

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The MPTP-treated mouse as a model of parkinsonism: how good is it?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Activation and lateralization of sensorimotor field for perioral biting reflex by intranigral GABA agonist and by systemic apomorphine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effect of the dopaminergic neurotoxin MPTP on cocaine-induced locomotor sensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of beta-adrenergic blockers on drug-induced tremors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Mesocorticolimbic dopaminergic network: functional and regulatory roles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Neurotoxicity of MPTP and uptake of MPPT into dopamine and norepinephrine neurons in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Acute ultrastructural and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

No apparent difference in the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the sympathetic system in NMRI and C57 BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPTP-induced Parkinsonism in minipigs: A behavioral, biochemical, and histological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Evaluation of bradykinesia induction by SM-9018, a novel 5-HT2 and D2 receptor antagonist, using the mouse pole test.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (NMPTP) in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Acute and long term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in tests of nociception in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Sprouting of the serotonergic afferents into striatum after selective lesion of the dopaminergic system by MPTP in adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Amphetamine induces hypermotility in MPTP-lesioned mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Evidence for resistance to MPTP in C57BL/6 x BALB/c F1 hybrids as compared with their progenitor strains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Preferences of individually housed TO strain laboratory mice for loose substrate or tubes for sleeping

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The weaver mutant mouse as a model of nigrostriatal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

A comparison between house mouse lines selected for attack latency or nest-building: evidence for a genetic basis of alternative behavioral strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Behavioral and biochemical changes following acute administration of MPTP and MPP+

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Cognitive changes in mice following moderate MPTP exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Effect of chronic administration of magnesium sulfate on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

The neuropsychology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Neuroanatomical substrate of behavioural impairment in weaver mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

L-dopa reverses the effects of MPP+ toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Increased sensitivity of mice to tremorogenic agents following MPP+.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Dissociation between biochemical and behavioral recovery in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Dopamine receptors and sensorimotor behavior in MPTP-treated mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Amine accumulation, catecholamine depletion and motor impairment in Macaca fasicularis and the C-57 black mouse after MPTP administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehyde or diethyldithiocarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900309-6

7 January 2021

10.1016/S0166-4328(01)00309-6

Identifiers

DOI

1 reference

2 August 2017

1 reference